Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
The World Allergy Organization Journal|October 6, 2021
Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III studyJing Li, Changzheng Wang, Chuntao Liu, et al.Nature Communications|December 16, 2018
Implication for alphavirus host-cell entry and assembly indicated by a 3.5Å resolution cryo-EM structureLihong Chen, Ming Wang, Dongjie Zhu, et al.Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 20, 2002
[Epidemiological survey on bronchial asthma in Liaoning province]Ping Chen, Runjiang Yu, Xianming Hou, et al.The Plant Journal : for Cell and Molecular Biology|December 19, 2023
The transcription factor PtoMYB142 enhances drought tolerance in Populus tomentosa by regulating gibberellin catabolismQin Song, Lingfei Kong, Jiarui Yang, et al.Journal of Genetics and Genomics = Yi Chuan Xue Bao|March 22, 2026
A single-nucleus and spatial transcriptomic atlas of poplar leaves reveals the regulation of leaf polarity and cuticle depositionYiling Li, Lingfei Kong, Xing Guo, et al.Experimental Neurology|November 7, 2023
Delayed recanalization reduced neuronal apoptosis and neurological deficits by enhancing liver-derived trefoil factor 3-mediated neuroprotection via LINGO2/EGFR/Src signaling pathway after middle cerebral artery occlusion in ratsDujuan Li, Lifei Lian, Lei Huang, et al.Nature Communications|September 19, 2023
Histidine modulates amyloid-like assembly of peptide nanomaterials and confers enzyme-like activityYe Yuan, Lei Chen, Lingfei Kong, et al.Cancer Medicine|August 3, 2023
Genomic alterations of oligodendrogliomas at distant recurrenceGuanzheng Liu, Chaojie Bu, Guangzhong Guo, et al.Iscience|August 31, 2023
Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomasGuanzheng Liu, Chaojie Bu, Guangzhong Guo, et al.Asian Pacific Journal of Allergy and Immunology|April 6, 2020
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and CaucasiansJing Li, Jing Yang, Lingfei Kong, et al.Pageof 9